Home
>
National Drug Code (NDC)
>
Spironolactone and Hydrochlorothiazide
Spironolactone and Hydrochlorothiazide - 0378-0141-05 - (spironolactone and hydrochlorothiazide)
Drug Information of Spironolactone and Hydrochlorothiazide
| Product NDC: | 0378-0141 |
| Proprietary Name: | Spironolactone and Hydrochlorothiazide |
| Non Proprietary Name: | spironolactone and hydrochlorothiazide |
| Active Ingredient(s): | 25; 25 mg/1; mg/1 & nbsp; spironolactone and hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Spironolactone and Hydrochlorothiazide
| Product NDC: | 0378-0141 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA086513 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120904 |
Package Information of Spironolactone and Hydrochlorothiazide
| Package NDC: | 0378-0141-05 |
| Package Description: | 500 TABLET in 1 BOTTLE, PLASTIC (0378-0141-05) |
NDC Information of Spironolactone and Hydrochlorothiazide
| NDC Code | 0378-0141-05 |
| Proprietary Name | Spironolactone and Hydrochlorothiazide |
| Package Description | 500 TABLET in 1 BOTTLE, PLASTIC (0378-0141-05) |
| Product NDC | 0378-0141 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | spironolactone and hydrochlorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120904 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
| Strength Number | 25; 25 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
